1. To conduct independent ethics reviews of human subjects research conducted by NUS students and staff.
2. To approve research in accordance with applicable laws, regulations and Guidelines in Singapore that govern or regulate research involving human subjects.
3. To monitor research projects, by way of regular reports, as determined by the NUS-IRB.
4. To submit an annual report, and such other reports, as may be called for by the President of NUS, or any other relevant authority.
1. All NUS activities related to human subject research, regardless of funding sources, will be guided by, but not limited to, the following laws / regulations and guidelines (both local and international):
Regulations - Human Biomedical Research Act (2015) - Personal Data Protection Act (2012) - Medicines Act [Chap. 176] - Medicines (Clinical Trial Regulations), 2000 - Singapore Guideline for Good Clinical Practice [Revised 1999] Guidelines - Guidelines by the Bioethics Advisory Committee, Singapore - NMEC: Guidelines on Research Involving Human Subjects (Sep. 1997) - US National Health Act - The Belmont Report - Internal Guidelines - Declaration of Helsinki - ICH E6 Good Clinical Practice
2. All NUS activities related to US federally conducted or supported human subject research will comply with both:
(a) The Terms of the Federalwide Assurance (FWA) for International (Non-U.S.) Institutions as stated in the US Department of Health and Human Services (DHHS) website; and
(b) ICH E6 Good Clinical Practice.
Our DHHS IRB registration number is IRB00003876 - Natl U Singapore IRB #1.
Our International IRB Organisation registration number is IORG0003245 - Natl U Singapore.
The Federalwide Assurance registration number is FWA00006418.